After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – General industry segment. The current market capitalization of Gilead Sciences, Inc is $146.22B. A total of 12.04 million shares were traded on the day, compared to an average of 7.61M shares.
In the most recent transaction, MERDAD V PARSEY bought 21,910 shares of GILD for 115.70 per share on Mar 03 ’25. In a previous transaction on Feb 18 ’25, GILEAD SCIENCES, INC. bought 1,363,636 shares at 11.00 per share. GILD shares that 10% Owner owns now total 31,424,760.
Among the insiders who sold shares, Dickinson Andrew D disposed of 2,500 shares on Feb 18 ’25 at a per-share price of $104.09. This resulted in the Chief Financial Officer holding 169,061 shares of GILD after the transaction. In another insider transaction, ANDREW DICKINSON bought 2,500 shares at $104.09 per share on Feb 18 ’25.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Gilead Sciences, Inc pays an annual dividend of $3.08, resulting in a dividend yield of 2.62%, and it has a price to earnings (P/E) ratio of 319.83. GILD’s most recent ex-dividend date was 3% when it declared a $0.79 quarterly dividend that was paid in cash on 3/14/2025. Previously, the company paid the dividend on 12/13/2024 with an ex-dividend date of 3.15%. The GILD stock dividend was $0.77 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, GILD has a high of $117.39 and a low of $62.07.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $15.51, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.31.
